Innovative Industrial Properties (IIPR) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
3 Aug, 2026Business overview and strategy
Operates as a diversified REIT with investments in cannabis and life sciences, holding 108 properties across 19 U.S. states and $2.4B in total invested capital as of June 2026.
Business model centers on long-term, triple-net leases, minimizing recurring capital expenditures and shifting revenue mix toward life sciences.
Strategic $270M investment in IQHQ expands exposure to life sciences, with fully funded commitments and rights to future asset sales.
Portfolio is diversified by geography, tenant, and property type, with 35+ tenants and a mix of industrial and retail assets.
Focus on serving two high-growth markets: cannabis (projected 8% CAGR through 2030) and life sciences, both benefiting from regulatory and innovation tailwinds.
Financial performance and capital structure
Q2 2026 total revenue reached $63.3M, with over $1.2B in dividends paid since inception and a 7% CAGR in AFFO/share from 2020 to Q2 2026.
Maintains a strong balance sheet with 1.7x net debt to adjusted EBITDA and $300M in available liquidity.
Raised $400M+ in exchangeable notes in June, with gross debt of $623.6M and common equity market capitalization of $1.7B.
Dividend per share grew at a 9% CAGR from 2020 to Q2 2026, and total return since inception is 486%, outperforming major indices.
AFFO and EBITDA reconciliations provided, highlighting adjustments for non-core and non-cash items.
Portfolio and market positioning
Top 10 states account for 89% of annualized base rent, with Illinois, Pennsylvania, and Massachusetts leading.
90% of properties are industrial, primarily supporting regulated cannabis cultivation, processing, and distribution.
Top tenants include AWH, PharmaCann, Green Thumb, and Curaleaf, with 62% public and 87% multi-state operators.
Life sciences investments now represent 12.2% of base rent, with strong rent premiums and stabilizing market fundamentals.
Underwriting emphasizes best-in-class operators, ongoing monitoring, and financial diligence.
Latest events from Innovative Industrial Properties
- 2025 revenue, AFFO, and net income strong; IQHQ investment and leasing drive future growth.IIPR
Q4 20256 Aug 2026 - Q2 2026 saw revenue and net income growth, strong liquidity, and strategic sector investments.IIPR
Q2 20264 Aug 2026 - Diversified REIT leverages triple-net leases and sector expertise for growth in cannabis and life sciences.IIPR
Company presentation3 Aug 2026 - Tenant defaults led to lower Q1 results, but liquidity and tenant refresh efforts remain robust.IIPR
Q1 20258 Jul 2026 - Q2 revenue up 4% to $79.8M, net income $41.7M, AFFO $2.29/share, and dividend raised 4.4%.IIPR
Q2 20248 Jul 2026 - Q3 2024 revenue was $76.5M with 95.7% occupancy and strong liquidity despite industry headwinds.IIPR
Q3 20248 Jul 2026 - Q1 2026 revenue was $69M, but tenant defaults and debt maturity threaten ongoing viability.IIPR
Q1 20265 May 2026 - Diversified REIT with robust growth, strong balance sheet, and expanding life sciences exposure.IIPR
Investor presentation5 May 2026 - 2025 featured robust financials, strategic diversification, and strong governance ahead of key shareholder votes.IIPR
Proxy filing23 Apr 2026